Rosario Notaro

6.0k total citations
91 papers, 3.3k citations indexed

About

Rosario Notaro is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, Rosario Notaro has authored 91 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Immunology, 38 papers in Hematology and 24 papers in Genetics. Recurrent topics in Rosario Notaro's work include Complement system in diseases (48 papers), Blood groups and transfusion (20 papers) and Renal Diseases and Glomerulopathies (17 papers). Rosario Notaro is often cited by papers focused on Complement system in diseases (48 papers), Blood groups and transfusion (20 papers) and Renal Diseases and Glomerulopathies (17 papers). Rosario Notaro collaborates with scholars based in Italy, United States and United Kingdom. Rosario Notaro's co-authors include Lucio Luzzatto, Andrea Banfi, Rodolfo Quarto, Giordano Bianchi, Ranieri Cancedda, Michela Sica, Bruno Rotoli, Antonio M. Risitano, David J. Araten and Maddalena Mastrogiacomo and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Rosario Notaro

89 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rosario Notaro Italy	31	1.4k	953	793	689	589	91	3.3k
Naohisa Tomosugi Japan	30	474 0.4×	761 0.8×	1.2k 1.5×	566 0.8×	589 1.0×	106	2.9k
Beverly Torok‐Storb United States	37	1.1k 0.8×	892 0.9×	1.7k 2.2×	1.6k 2.4×	208 0.4×	83	4.7k
Hartmut Weiler United States	35	691 0.5×	536 0.6×	2.2k 2.8×	1.2k 1.7×	191 0.3×	121	4.5k
Mark J. Koury United States	40	598 0.4×	1.2k 1.3×	2.1k 2.6×	1.9k 2.7×	467 0.8×	123	5.5k
Naomi L. Esmon United States	27	2.2k 1.6×	562 0.6×	1.9k 2.4×	919 1.3×	317 0.5×	45	4.5k
Karel J.M. Assmann Netherlands	34	1.3k 0.9×	214 0.2×	396 0.5×	993 1.4×	1.4k 2.3×	98	4.0k
Carmine Selleri Italy	39	1.4k 1.1×	862 0.9×	2.4k 3.0×	1.5k 2.1×	116 0.2×	202	5.4k
Waander L. van Heerde Netherlands	32	572 0.4×	374 0.4×	1.2k 1.6×	1.4k 2.0×	120 0.2×	102	3.6k
Teresa Bellón Spain	38	2.9k 2.1×	339 0.4×	282 0.4×	1.2k 1.7×	167 0.3×	102	5.9k
Alan H. Lazarus Canada	35	1.8k 1.3×	347 0.4×	2.2k 2.8×	625 0.9×	108 0.2×	117	4.3k

Countries citing papers authored by Rosario Notaro

Since Specialization

Citations

This map shows the geographic impact of Rosario Notaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosario Notaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosario Notaro more than expected).

Fields of papers citing papers by Rosario Notaro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosario Notaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosario Notaro. The network helps show where Rosario Notaro may publish in the future.

Co-authorship network of co-authors of Rosario Notaro

This figure shows the co-authorship network connecting the top 25 collaborators of Rosario Notaro. A scholar is included among the top collaborators of Rosario Notaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosario Notaro. Rosario Notaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kulasekararaj, Austin, Robert A. Brodsky, Hubert Schrezenmeier, et al.. (2025). Ravulizumab demonstrates long-term efficacy, safety and favorable patient survival in patients with paroxysmal nocturnal hemoglobinuria. Annals of Hematology. 104(1). 81–94. 2 indexed citations

Matteo, Sergio Di, et al.. (2024). Cost-Utility Analysis Comparing Pegcetacoplan to Anti-C5 Monoclonal Antibodies in the Treatment of Paroxysmal Nocturnal Hemoglobinuria. ClinicoEconomics and Outcomes Research. Volume 16. 225–232.

Girmenia, Corrado, Wilma Barcellini, Paola Bianchi, et al.. (2022). Management of infection in PNH patients treated with eculizumab or other complement inhibitors: Unmet clinical needs. Blood Reviews. 58. 101013–101013. 11 indexed citations

Notaro, Rosario & Lucio Luzzatto. (2022). Breakthrough Hemolysis in PNH with Proximal or Terminal Complement Inhibition. New England Journal of Medicine. 387(2). 160–166. 56 indexed citations

Schrezenmeier, Hubert, Jong Wook Lee, A. Bradford Hill, et al.. (2020). Efficacy and Safety of Concomitant Use of Ravulizumab and IST in Patients with Paroxysmal Nocturnal Hemoglobinuria up to 52 Weeks. Blood. 136(Supplement 1). 37–38. 1 indexed citations

Torre, Eugenio, et al.. (2020). ETV4 promotes late development of prostatic intraepithelial neoplasia and cell proliferation through direct and p53-mediated downregulation of p21. Journal of Hematology & Oncology. 13(1). 112–112. 20 indexed citations

Kulasekararaj, Austin, Antonio M. Risitano, Jaroslaw P. Maciejewski, et al.. (2019). A Phase 2 Open-Label Study of Danicopan (ACH-0144471) in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have an Inadequate Response to Eculizumab Monotherapy. Blood. 134(Supplement_1). 3514–3514. 13 indexed citations

Risitano, Antonio M., Rosario Notaro, Caterina Pascariello, et al.. (2012). The complement receptor 2/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complement-mediated hemolysis and C3 fragment opsonization. Blood. 119(26). 6307–6316. 100 indexed citations

Lunardi, Gianluigi, Patrizia Piccioli, Paolo Bruzzi, et al.. (2012). Plasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in postmenopausal women with early breast cancer treated with letrozole. Breast Cancer Research and Treatment. 137(1). 167–174. 14 indexed citations

10.

Mannelli, Francesco, Sara Bencini, Benedetta Peruzzi, et al.. (2012). A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria. Cytometry Part B Clinical Cytometry. 84B(2). 71–81. 5 indexed citations

11.

Araten, David J., Rosario Notaro, Howard T. Thaler, et al.. (2011). Thrombolytic therapy is effective in paroxysmal nocturnal hemoglobinuria: a series of nine patients and a review of the literature. Haematologica. 97(3). 344–352. 20 indexed citations

12.

Ortolan, Erika, Elena Tibaldi, Giovanni Maria Garbarino, et al.. (2006). CD157 plays a pivotal role in neutrophil transendothelial migration. Blood. 108(13). 4214–4222. 38 indexed citations

13.

Bessler, Monica, Vittorio Rosti, Yufeng Peng, et al.. (2002). Glycosylphosphatidylinositol-linked proteins are required for maintenance of a normal peripheral lymphoid compartment but not for lymphocyte development. European Journal of Immunology. 32(9). 2607–2616. 13 indexed citations

14.

Karadimitris, Anastasios, Ke Li, Rosario Notaro, et al.. (2001). Association of clonal T‐cell large granular lymphocyte disease and paroxysmal nocturnal haemoglobinuria (PNH): further evidence for a pathogenetic link between T cells, aplastic anaemia and PNH. British Journal of Haematology. 115(4). 1010–1014. 41 indexed citations

15.

Angioletti, Maria De, Ana Rovira, Rosario Notaro, et al.. (2001). Glucose 6-phosphate dehydrogenase expression is less prone to variegation when driven by its own promoter. Gene. 267(2). 221–231. 6 indexed citations

16.

Karadimitris, Anastasios, Rosario Notaro, Guenther Koehne, Irene Roberts, & Lucio Luzzatto. (2000). PNH cells are as sensitive to T-cell-mediated lysis as their normal counterparts: implications for the pathogenesis of paroxysmal nocturnal haemoglobinuria. British Journal of Haematology. 111(4). 1158–1163. 30 indexed citations

17.

Persico, Marcello, Amalia De Renzo, Eliana Persico, et al.. (1998). HEPATITIS G VIRUS IN PATIENTS WITH HODGKIN'S LYMPHOMA. British Journal of Haematology. 103(4). 1206–1207. 3 indexed citations

18.

Caraglia, Michele, Carmine Selleri, Stefano Pepe, et al.. (1998). Desferioxamine increases iron depletion and apoptosis induced by ara‐C of human myeloid leukaemic cells. British Journal of Haematology. 102(3). 746–752. 111 indexed citations

19.

Capone, Domênico, et al.. (1997). Effects of different routes of cyclosporin A administration on blood levels in patients undergoing bone marrow transplantation. Bone Marrow Transplantation. 19(4). 369–372. 5 indexed citations

20.

Selleri, Carmine, et al.. (1991). Danazol: in vitro effects on human hemopoiesis and in vivo activity in hypoplastic and myelodysplastic disorders. European Journal Of Haematology. 47(3). 197–203. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact